testing supplies are required to continue Newborn DNA Analysis testing

Fisher Scientific LLC has been awarded a contract by the State of Texas to provide testing supplies required to support Newborn DNA Analysis testing operations. The contract was executed on March 30, 2026, and is classified under NIGP Category 97212 (DNA Sequencing). The supplies procured under this agreement are intended to maintain continuity of newborn screening and genetic analysis capabilities within the state's public health infrastructure.

The specific contract value, period of performance, and organizational unit responsible for the award are not detailed in the available documentation. Fisher Scientific LLC, serving as the prime contractor, will deliver the necessary laboratory supplies and materials required for the ongoing DNA analysis operations. Additional details regarding the location of performance, annual value, cumulative contract value, and contract duration would be required for a complete assessment of the award's scope and financial parameters.